藥物研發市場中的人工智慧（按治療領域、應用和地區）

藥物研發人工智慧市場規模預計在 2025 年達到 16.99 億美元，預計到 2032 年將達到 47.441 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 15.8%。

人工智慧 (AI) 是創造智慧機器（尤其是智慧型電腦程式）的科學與工程。 AI 技術幾乎可以應用於製藥科學的各個方面，包括藥物發現、藥物開發、藥物再利用、藥物代謝預測、藥物毒性分析、藥物生產效率提升以及臨床試驗。這些技術統稱為 AIDD（藥物發現中的人工智慧）。

市場動態：

不斷進步的技術、市場參與企業的產品研究、合作研究、研發協議以及市場參與企業的其他無機成長策略是預計在預測期內促進全球藥物研發市場人工智慧成長的關鍵因素。

例如，2023年5月16日，Google雲端在Bio-IT世界大會上宣布了兩款全新的AI驅動生命科學解決方案，旨在加速生物技術公司、製藥公司和上市公司的藥物發現和精準醫療。標靶和先導化合物識別套件可幫助研究人員識別胺基酸的功能並預測蛋白質結構。多組學套件可加速基因組數據的發現和解讀，幫助企業設計精準藥物。

本研究的主要特點

• 本報告對全球藥物研發人工智慧市場進行了詳細分析，並以 2024 年為基準年，給出了預測期 2025 年至 2032 年的市場規模和年複合成長率（CAGR%）。
• 它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
• 該報告涵蓋了全球藥物研發人工智慧市場的主要企業概況，基於以下參數，例如公司亮點、產品系列、關鍵亮點、財務表現和策略。
• 報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興車型、市場擴張和行銷策略做出明智的決策。
• 全球藥物研發人工智慧市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員將透過用於分析全球藥物研發人工智慧市場的各種策略矩陣來促進其決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
  • 控制藥物開發和發現成本的需求日益增加
  • 慢性病的增加促進了個人化醫療的發展
  • 醫療保健和藥物研發領域的巨量資料和資訊爆炸
  • 擴大人工智慧在各醫療領域的應用
• 影響分析
• 主要亮點
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購場景

第4章 藥物研發市場中的人工智慧—冠狀病毒 (COVID-19) 大流行的影響

• COVID-19流行病學
• 供需側分析
• 經濟影響

5. 2020 年至 2032 年藥物研發市場中人工智慧的治療領域

• 腫瘤學
• 神經退化性疾病
• 心血管疾病
• 代謝疾病
• 感染疾病
• 其他

6. 人工智慧藥物研發市場（按應用分類），2020 年至 2032 年

• 藥物最佳化和再利用
• 臨床前試驗
• 其他

7. 2020 年至 2032 年藥物研發市場中的人工智慧（按地區）

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第8章 競爭態勢

• IBM Corporation（Ibm Watson Health）
• Exscientia
• GNS Healthcare
• Alphabet, Inc.（DEEPMIND）
• Benevolent AI
• Biosymetrics
• Euretos
• Berg LLC.
• Atomwise, Inc.

第9章 章節

• 調查方法
• 關於出版商

Artificial Intelligence in Drug Discovery Market is estimated to be valued at USD 1,699.0 Mn in 2025 and is expected to reach USD 4,744.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 15.8% from 2025 to 2032.

The Artificial intelligence (AI) is the science and engineering of making intelligent machines, especially intelligent computer programs. The AI techniques are also applicable to drug discovery, drug development, drug repurposing, drug metabolism prediction, drug toxicity analysis, improving pharmaceutical productivity, clinical trials and almost all aspects of pharmaceutical sciences. All these techniques are collectively considered under AIDD (Artificial Intelligence in Drug Discovery).

Market Dynamics:

Increasing technological advancements, product launches by market players, collaborations, research and development agreements and other inorganic growth strategies by market players are major factors expected to augment growth of the global artificial intelligence in drug discovery market over the forecast period.

For instance, on May 16 2023, Google Cloud, in Bio-IT World Conference announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. The Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Multiomics Suite accelerates the discovery and interpretation of genomic data, helping companies design precision treatments.

Key features of the study:

• This report provides in-depth analysis of the global artificial intelligence in drug discovery market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global artificial intelligence in drug discovery market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include IBM Corporation (Ibm Watson Health), Exscientia, GNS Healthcare, Alphabet, Inc. (DEEPMIND), Benevolent AI, Biosymetrics, Euretos, Berg LLC., Atomwise, Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global artificial intelligence in drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in drug discovery market.

Detailed Segmentation:

• Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Space:
  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Infectious Diseases
  • Other
• Global Artificial Intelligence in Drug Discovery Market, By Application:
  • Drug Optimization & Repurposing
  • Preclinical Testing
  • Others
• Global Artificial Intelligence in Drug Discovery Market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • IBM Corporation (Ibm Watson Health)
  • Exscientia
  • GNS Healthcare
  • Alphabet, Inc. (DEEPMIND)
  • Benevolent AI
  • Biosymetrics
  • Euretos
  • Berg LLC.
  • Atomwise, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Therapeutic Space
  • Market Snapshot, By Application
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising need to curb drug development and discovery costs
  • Rising prevalence of chronic diseases supporting development of personalized drugs
  • Big data and information explosion in healthcare and drug discovery
  • Growing applications of AI in various healthcare areas
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Artificial Intelligence in Drug Discovery Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Artificial Intelligence in Drug Discovery Market, By Therapeutic Space, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Neurodegenerative Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Metabolic Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Artificial Intelligence in Drug Discovery Market, By Application, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Drug Optimization & Repurposing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Preclinical Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Artificial Intelligence in Drug Discovery Market, By Geography, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)

8. Competitive Landscape

• IBM Corporation (Ibm Watson Health)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Exscientia
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GNS Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Alphabet, Inc. (DEEPMIND)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Benevolent AI
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Biosymetrics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Euretos
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Berg LLC.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Atomwise, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us